Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DINAMIT

Financiado

Cerrado

Dual Imaging Nano Micro sized Theranostics against cancer

Objectives of the joint exchange program DINaMiT is to develop state-of-the art remotely responsive magnetic/metal nanoparticle functionalized drug delivery carriers for dual optical and magnetic resonance imaging modalities, equi... ver más

31/07/2016

CHARITE UNIVERSIT...

265K€

Presupuesto del proyecto: 265K€

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

CHARITE UNIVERSITAETSMEDIZI...

0.00€ | Lider

UGent

N.D. | Participante

UNITO

N.D. | Participante

Proyectos interesantes

RYC2021-032448-I

Medical Technol...

Nanotechnology

236K€ Cerrado

NanoSCAN

Medical Technol...

Nanotechnology

2M€ Cerrado

NANO-PEFIS

Medical Technol...

Nanotechnology

Cerrado

LCT

Medical Technol...

Nanotechnology

Cerrado

DESARROLLO Y APLICACIÓN CLÍNICA DE UN SISTEMA...

Medical Technol...

Nanotechnology

514K€ Cerrado

ONCOTHERANOSTICS

Nanotechnology

Medical Technol...

257K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 265K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Objectives of the joint exchange program DINaMiT is to develop state-of-the art remotely responsive magnetic/metal nanoparticle functionalized drug delivery carriers for dual optical and magnetic resonance imaging modalities, equip such probes with theranostic detection/delivery capabilities and apply them for in-vivo study of anticancer drugs. To implement ambitious goals of such a program seven work-packages will be pursued. Each work-package will constitute of a necessary step for reaching the milestones and overall goals of the exchange programme. Functionalization of delivery carriers by nanoparticles is an important issue of successfully achieving the goals of the project. Optical imaging is the technique of choice for working with cell cultures and for routine fluorescent sample characterization. A significant advancement of the scientific research program is addition of magnetic response capabilities for such carriers, which results into dual optical / magnetically responsive system. Functionalized by nanoparticles, delivery carriers can be remotely activated based on the localized heating, which induces the permeability change of the carriers, but which does not affect the surrounding tissue. We envision using two-photon microscopy for deeper in-tissue reach. Magnetic functionality is viewed as a complementary approach which will allow even deeper reach. Magnetic resonance imaging (MRI) is a technique widely used for in-vivo diagnostic and tracking investigation. Polymeric and natural (red blood cells) delivery vehicles will be used for assembling ther-anostic carriers. Theranostic functionalities will be introduced by assembling the so-called multicompartment structures. Indeed, after such carriers are assembled and imaging/activation system is developed, in-vitro as well as in-vivo applications of such a system will be pursued. For in-vitro applications cell culture tests will be used, while that will be transferred for real in-vivo applications.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores